Idiopathic Pulmonary Fibrosis
📧 Sign up to get email alerts when something new happens for Idiopathic Pulmonary Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: GKT137831 in IPF Patients with Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 trial of GKT137831 in idiopathic pulmonary fibrosis has completed, per the update from the University of Alabama at Birmingham.
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: 23andMe IPF Research Study
This is a clinical trial update for the 23andMe IPF research study. The study on idiopathic pulmonary fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-02Clinical Trial Update: A Study Evaluating the Safety and Efficacy of ENV-101 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
Phase 2 trial evaluating ENV-101 for idiopathic pulmonary fibrosis has completed, with an update on safety and efficacy.
-
FDA approval · 2024-11-26FDA Approved: PIRFENIDONE — Supplemental Application (Teva Pharmaceuticals, Inc.)
FDA approved Teva Pharmaceuticals' supplemental application for pirfenidone (ANDA 212759).
-
CLINICAL_TRIALS research · 2024-11-22Clinical Trial Update: Precision Diagnosis and Care for Families With Pulmonary Fibrosis in Ireland
This clinical trial update indicates ongoing recruitment for a study on precision diagnosis and care for families affected by pulmonary fibr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: The Safety, Tolerability, and Pharmacokinetic Study of SC1011 in Healthy Subjects. [Phase 1]
Phase 1 safety, tolerability, and pharmacokinetic study of SC1011 in healthy subjects has been completed.
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2, Phase 3]
SC1011 is being studied in a Phase 2/Phase 3 trial for idiopathic pulmonary fibrosis, with recruiting status.
-
CLINICAL_TRIALS research · 2024-11-14Clinical Trial Update: Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial is evaluating saracatinib for idiopathic pulmonary fibrosis and remains active but not recruiting.
-
CLINICAL_TRIALS research · 2024-11-14Clinical Trial Update: The Role of Laryngopharyngeal Reflux in IPF
This clinical trial at National Jewish Health investigates the role of laryngopharyngeal reflux in idiopathic pulmonary fibrosis and related…
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: The First-in-human Study of SRN-001 in Healthy Participants [Phase 1]
This report communicates completion of a first-in-human Phase 1 study of SRN-001 in healthy participants to evaluate safety and tolerability…
-
CLINICAL_TRIALS research · 2024-10-31Clinical Trial Update: Determination of Functional Exercise Capacity, Respiratory Muscle Endurance in Idiopathic Pulmonary Fibrosis
A clinical trial evaluating functional exercise capacity and respiratory muscle endurance in idiopathic pulmonary fibrosis. The study status…
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Comparison of the Efficacy of Pirfenidone and Nintedanipine in Pulmonary Fibrosis
A completed clinical trial directly comparing pirfenidone and nintedanib for efficacy in idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: All-Case Surveillance of Ofev in Patients With IPF in Japan
Completed all-case surveillance study of Ofev (nintedanib) in Japanese patients with idiopathic pulmonary fibrosis; results were posted in O…
-
FDA label_change · 2024-10-11FDA Approved: OFEV — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for OFEV (nintedanib) from Boehringer Ingelheim Pharmaceuticals, Inc., potentially resulting in a la…
-
CLINICAL_TRIALS research · 2024-10-08Clinical Trial Update: Current Status of Diagnosis, Treatment and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis
A clinical trial update describing the current status of a study on the diagnosis, treatment, and quality of life for patients with idiopath…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: Burden of Nintedanib Non-adherence Among Idiopathic Pulmonary Fibrosis (IPF) Patients
A completed clinical trial evaluates the burden of non-adherence to nintedanib in patients with idiopathic pulmonary fibrosis. Results have …
-
CLINICAL_TRIALS research · 2024-09-26Clinical Trial Update: Assessment of Serum CD25 Level in Systemic Sclerosis Patients with or Without Interstitial Lung Disease (ILD)
A not-yet-recruiting clinical trial sponsored by Assiut University to measure serum SCD25 levels in rheumatoid arthritis, systemic sclerosis…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) [Phase 3]
Phase 3 Zephyrus I trial evaluating pamrevlumab for idiopathic pulmonary fibrosis has been terminated, and results have been posted on clini…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions [Phase 1]
A Phase 1 pharmacokinetic study comparing pirfenidone modified-release tablets to standard pirfenidone tablets in healthy volunteers under f…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis
This clinical trial update notes the completion of a study characterizing apolipoprotein A-I pathways in idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Comparative Pharmacokinetic(PK) Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions [Phase 1]
Phase 1 study comparing pharmacokinetics of pirfenidone modified-release tablets with standard pirfenidone tablets in healthy subjects under…
-
CLINICAL_TRIALS trial_result · 2024-08-30Clinical Trial Update: Multi-elemental Imaging of Lung Tissues With LIBS (Laser-induced Breakdown Spectroscopy)
This clinical trial update reports the completion of a study using laser-induced breakdown spectroscopy to image elemental composition in lu…
-
CLINICAL_TRIALS research · 2024-08-23Clinical Trial Update: Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 clinical trial update evaluating RXC007 for idiopathic pulmonary fibrosis, focusing on safety, pharmacokinetics, pharmacodynamics, a…
-
CLINICAL_TRIALS trial_result · 2024-08-22Clinical Trial Update: Post Marketing Surveillance of Nintedanib in Indian Patients With Idiopathic Pulmonary Fibrosis
This post-marketing surveillance study from Boehringer Ingelheim evaluates nintedanib in Indian patients with idiopathic pulmonary fibrosis,…
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: The Assessment of Nutritional Status of Patients With IPF [NA]
The clinical trial assessed the nutritional status of patients with idiopathic pulmonary fibrosis and has completed.